# Treatment of SFA Lesions With 480 Biomedical STANZA™ Drug-Eluting Resorbable Scaffold (DRS) System

> **NCT02097082** · NA · COMPLETED · sponsor: **480 Biomedical** · enrollment: 28 (actual)

## Conditions studied

- Peripheral Arterial Disease
- Intermittent Claudication
- Vascular Diseases
- Cardiovascular Diseases

## Interventions

- **DEVICE:** STANZA Drug-eluting resorbable Scaffold

## Key facts

- **NCT ID:** NCT02097082
- **Lead sponsor:** 480 Biomedical
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-10
- **Primary completion:** 2016-03-30
- **Final completion:** 2017-05
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2019-09-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02097082

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02097082, "Treatment of SFA Lesions With 480 Biomedical STANZA™ Drug-Eluting Resorbable Scaffold (DRS) System". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT02097082. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*